Cooper C. Collins, Director at TherapeuticsMD, Inc. (TXMD), bought 30,000 shares at $3.33 ($100K) on 2019-05-13, disclosed to the SEC on 2019-05-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| TXMD | BUY | 2021-11-22 | $580K | — | Filing → |
| TXMD | BUY | 2021-08-19 | $725K | — | Filing → |
| TXMD | BUY | 2020-06-10 | $107K | — | Filing → |